NAGE Q1 2022 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena

NAGENiagen Bioscience Inc

$423M

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$17M+17.5% YoY

Gross Profit

$11M61.0% margin

Operating Income

-$8M-44.8% margin

Net Income

-$8M-44.8% margin

EPS (Diluted)

$-0.11

QoQ Revenue Growth

-2.8%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$53M

Total Liabilities

$27M

Stockholders' Equity

$26M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17M	$15M	+17.5%
Gross Profit	$11M	$9M	+14.1%
Operating Income	-$8M	-$7M	-5.0%
Net Income	-$8M	-$7M	-4.9%